These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 33422763

  • 1. Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
    Chaudhary P, Marracci GH, Calkins E, Pocius E, Bensen AL, Scanlan TS, Emery B, Bourdette DN.
    J Neuroimmunol; 2021 Mar 15; 352():577468. PubMed ID: 33422763
    [Abstract] [Full Text] [Related]

  • 2. Myelin repair stimulated by CNS-selective thyroid hormone action.
    Hartley MD, Banerji T, Tagge IJ, Kirkemo LL, Chaudhary P, Calkins E, Galipeau D, Shokat MD, DeBell MJ, Van Leuven S, Miller H, Marracci G, Pocius E, Banerji T, Ferrara SJ, Meinig JM, Emery B, Bourdette D, Scanlan TS.
    JCI Insight; 2019 Apr 18; 4(8):. PubMed ID: 30996143
    [Abstract] [Full Text] [Related]

  • 3. Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.
    Bárez-López S, Hartley MD, Grijota-Martínez C, Scanlan TS, Guadaño-Ferraz A.
    Thyroid; 2018 Sep 18; 28(9):1211-1220. PubMed ID: 29845892
    [Abstract] [Full Text] [Related]

  • 4. Oligodendrocyte-specific ATF4 inactivation does not influence the development of EAE.
    Yue Y, Stanojlovic M, Lin Y, Karsenty G, Lin W.
    J Neuroinflammation; 2019 Feb 01; 16(1):23. PubMed ID: 30709400
    [Abstract] [Full Text] [Related]

  • 5. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ.
    Glia; 2006 May 01; 53(7):696-703. PubMed ID: 16498619
    [Abstract] [Full Text] [Related]

  • 6. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
    Zhang J, Zhang ZG, Li Y, Lu M, Zhang Y, Elias SB, Chopp M.
    Neurobiol Dis; 2016 Apr 01; 88():85-95. PubMed ID: 26805386
    [Abstract] [Full Text] [Related]

  • 7. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases.
    Lin Y, Huang G, Jamison S, Li J, Harding HP, Ron D, Lin W.
    Am J Pathol; 2014 Feb 01; 184(2):507-19. PubMed ID: 24269558
    [Abstract] [Full Text] [Related]

  • 8. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J, Karacivi A, Stormanns ER, Recks MS, Kuerten S.
    PLoS One; 2015 Feb 01; 10(12):e0144847. PubMed ID: 26658811
    [Abstract] [Full Text] [Related]

  • 9. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
    Fletcher JL, Wood RJ, Nguyen J, Norman EML, Jun CMK, Prawdiuk AR, Biemond M, Nguyen HTH, Northfield SE, Hughes RA, Gonsalvez DG, Xiao J, Murray SS.
    J Neurosci; 2018 Aug 08; 38(32):7088-7099. PubMed ID: 29976621
    [Abstract] [Full Text] [Related]

  • 10. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ, Hasselmann J, Augello C, Moore S, Tiwari-Woodruff SK.
    J Steroid Biochem Mol Biol; 2016 Jun 08; 160():43-52. PubMed ID: 26776441
    [Abstract] [Full Text] [Related]

  • 11. Hypothalamic-Pituitary-Thyroid Axis Perturbations in Male Mice by CNS-Penetrating Thyromimetics.
    Ferrara SJ, Bourdette D, Scanlan TS.
    Endocrinology; 2018 Jul 01; 159(7):2733-2740. PubMed ID: 29846550
    [Abstract] [Full Text] [Related]

  • 12. Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Durose WW, Shimizu T, Li J, Abe M, Sakimura K, Chetsawang B, Tanaka KF, Suzumura A, Tohyama K, Ikenaka K.
    J Neurochem; 2019 Feb 01; 148(3):413-425. PubMed ID: 30152001
    [Abstract] [Full Text] [Related]

  • 13. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, Mun Aui P, Siatskas C, Litwak S, Fehlings MG, Strittmatter SM, Bernard CC.
    Brain; 2012 Jun 01; 135(Pt 6):1794-818. PubMed ID: 22544872
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
    Madsen PM, Pinto M, Patel S, McCarthy S, Gao H, Taherian M, Karmally S, Pereira CV, Dvoriantchikova G, Ivanov D, Tanaka KF, Moraes CT, Brambilla R.
    J Neurosci; 2017 Oct 18; 37(42):10185-10199. PubMed ID: 28931570
    [Abstract] [Full Text] [Related]

  • 15. Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis.
    Girolamo F, Ferrara G, Strippoli M, Rizzi M, Errede M, Trojano M, Perris R, Roncali L, Svelto M, Mennini T, Virgintino D.
    Neurobiol Dis; 2011 Sep 18; 43(3):678-89. PubMed ID: 21679768
    [Abstract] [Full Text] [Related]

  • 16. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis.
    Kumar S, Patel R, Moore S, Crawford DK, Suwanna N, Mangiardi M, Tiwari-Woodruff SK.
    Neurobiol Dis; 2013 Aug 18; 56():131-44. PubMed ID: 23603111
    [Abstract] [Full Text] [Related]

  • 17. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN, Warrington AE, Denic A, Wootla B, Rodriguez M.
    Hum Antibodies; 2017 Aug 18; 25(3-4):121-129. PubMed ID: 28269761
    [Abstract] [Full Text] [Related]

  • 18. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
    Keough MB, Jensen SK, Yong VW.
    J Vis Exp; 2015 Mar 26; (97):. PubMed ID: 25867716
    [Abstract] [Full Text] [Related]

  • 19. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.
    Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK.
    Brain; 2010 Oct 26; 133(10):2999-3016. PubMed ID: 20858739
    [Abstract] [Full Text] [Related]

  • 20. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 26; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.